1. Home
  2. HTBK vs LXRX Comparison

HTBK vs LXRX Comparison

Compare HTBK & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTBK
  • LXRX
  • Stock Information
  • Founded
  • HTBK 1997
  • LXRX 1995
  • Country
  • HTBK United States
  • LXRX United States
  • Employees
  • HTBK N/A
  • LXRX N/A
  • Industry
  • HTBK Major Banks
  • LXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTBK Finance
  • LXRX Health Care
  • Exchange
  • HTBK Nasdaq
  • LXRX Nasdaq
  • Market Cap
  • HTBK 588.2M
  • LXRX 228.8M
  • IPO Year
  • HTBK 1998
  • LXRX 2000
  • Fundamental
  • Price
  • HTBK $10.40
  • LXRX $1.08
  • Analyst Decision
  • HTBK Buy
  • LXRX Buy
  • Analyst Count
  • HTBK 3
  • LXRX 4
  • Target Price
  • HTBK $11.33
  • LXRX $3.67
  • AVG Volume (30 Days)
  • HTBK 464.8K
  • LXRX 5.0M
  • Earning Date
  • HTBK 07-24-2025
  • LXRX 07-31-2025
  • Dividend Yield
  • HTBK 4.99%
  • LXRX N/A
  • EPS Growth
  • HTBK N/A
  • LXRX N/A
  • EPS
  • HTBK 0.68
  • LXRX N/A
  • Revenue
  • HTBK $174,083,000.00
  • LXRX $31,213,000.00
  • Revenue This Year
  • HTBK $7.71
  • LXRX N/A
  • Revenue Next Year
  • HTBK $6.13
  • LXRX N/A
  • P/E Ratio
  • HTBK $15.33
  • LXRX N/A
  • Revenue Growth
  • HTBK N/A
  • LXRX 1251.21
  • 52 Week Low
  • HTBK $8.09
  • LXRX $0.28
  • 52 Week High
  • HTBK $11.27
  • LXRX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • HTBK 66.25
  • LXRX 66.94
  • Support Level
  • HTBK $10.41
  • LXRX $0.84
  • Resistance Level
  • HTBK $10.77
  • LXRX $1.19
  • Average True Range (ATR)
  • HTBK 0.23
  • LXRX 0.09
  • MACD
  • HTBK 0.05
  • LXRX 0.02
  • Stochastic Oscillator
  • HTBK 75.00
  • LXRX 76.60

About HTBK Heritage Commerce Corp

Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: